95-76-1: Gefitinib Impurity III
Also known as 3,4-Dichloroaniline or 3,4-Dichlorobenzenamine is a Process impurity of Gefitinib which is a selective tyrosine kinase receptor inhibitor used in the therapy of non-small cell lung cancer.
Additional information on CAS 95-76-1
3,4-Dichloroaniline; 3, 4-Dichlorobenzenamine; 3, 4-Dichlorophenylamine; 4, 5-Dichloroaniline; 4-Amino-1, 2-dichlorobenzene; DCA; LY 004892; NSC 247; m, p-Dichloroaniline;
Chandrashekara, K. A., et al. “Separation and Estimation of Process-Related Impurities of Gefitinib by Reverse-Phase High-Performance Liquid Chromatography.” Journal of Chromatographic Science, vol. 52, no. 8, July 2013, pp. 799–805, https://doi.org/10.1093/chromsci/bmt116.
Other products related to gefitinib
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|